Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Professional Survey Report 2016

July 2016 | 121 pages | ID: GDACEE0202FEN
QYResearch

Abstracts

This report studies Commercializing Biomarkers in Therapeutic and Diagnostic Applications in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• 20/20 GeneSystems
• Activiomic
• Advanced Cell Diagnostics
• Agendia
• Almac Diagnostics
• Arrayit
• Astute Medical
• Asuragen
• BG Medicine
• Biocartis

By types, the market can be split into

• Consumables
• Services
• Software

By Application, the market can be split into

• Oncology
• Cardiology
• Neurology
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Professional Survey Report 2016

1 INDUSTRY OVERVIEW OF COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS

1.1 Definition and Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
  1.1.1 Definition of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
  1.1.2 Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.2 Classification of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
  1.2.1 Consumables
  1.2.2 Services
  1.2.3 Software
1.3 Applications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
  1.3.1 Oncology
  1.3.2 Cardiology
  1.3.3 Neurology
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.3 Manufacturing Process Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.4 Industry Chain Structure of Commercializing Biomarkers in Therapeutic and Diagnostic Applications

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS

3.1 Capacity and Commercial Production Date of Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Manufacturers in 2015

4 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016E Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Capacity and Growth Rate Analysis
  4.2.2 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016E Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate Analysis
  4.3.2 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016E Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price
  4.4.2 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Analysis (Company Segment)

5 COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS REGIONAL MARKET ANALYSIS

5.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Analysis
  5.1.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Overview
  5.1.2 North America 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Analysis
  5.1.4 North America 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Analysis
5.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Analysis
  5.2.1 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Overview
  5.2.2 China 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Analysis
  5.2.4 China 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Analysis
5.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Analysis
  5.3.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Overview
  5.3.2 Europe 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Analysis
  5.3.4 Europe 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Analysis
5.4 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Analysis
  5.4.1 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Overview
  5.4.2 Southeast Asia 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Analysis
  5.4.4 Southeast Asia 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Analysis
5.5 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Analysis
  5.5.1 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Overview
  5.5.2 Japan 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Analysis
  5.5.4 Japan 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Analysis
5.6 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Analysis
  5.6.1 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Overview
  5.6.2 India 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Analysis
  5.6.4 India 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Analysis

6 GLOBAL 2011-2016E COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type
6.2 Different Types of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Interview Price Analysis
6.3 Different Types of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Driving Factors Analysis
  6.3.1 Consumables of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Driving Factor Analysis
  6.3.2 Services of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Driving Factor Analysis
  6.3.3 Software of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Driving Factor Analysis

7 GLOBAL 2011-2016E COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Application
7.2 Different Application of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Interview Price Analysis
7.3 Different Application of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Driving Factors Analysis
  7.3.1 Oncology of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Driving Factor Analysis
  7.3.2 Cardiology of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Driving Factor Analysis
  7.3.3 Neurology of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Driving Factor Analysis
  7.3.4 Others of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS

8.1 20/20 GeneSystems
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Type I
    8.1.2.2 Type II
    8.1.2.3 Type III
  8.1.3 20/20 GeneSystems 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 20/20 GeneSystems 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.2 Activiomic
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Type I
    8.2.2.2 Type II
    8.2.2.3 Type III
  8.2.3 Activiomic 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Activiomic 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.3 Advanced Cell Diagnostics
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Type I
    8.3.2.2 Type II
    8.3.2.3 Type III
  8.3.3 Advanced Cell Diagnostics 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Advanced Cell Diagnostics 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.4 Agendia
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Type I
    8.4.2.2 Type II
    8.4.2.3 Type III
  8.4.3 Agendia 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Agendia 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.5 Almac Diagnostics
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Type I
    8.5.2.2 Type II
    8.5.2.3 Type III
  8.5.3 Almac Diagnostics 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Almac Diagnostics 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.6 Arrayit
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Type I
    8.6.2.2 Type II
    8.6.2.3 Type III
  8.6.3 Arrayit 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Arrayit 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.7 Astute Medical
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Type I
    8.7.2.2 Type II
    8.7.2.3 Type III
  8.7.3 Astute Medical 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Astute Medical 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.8 Asuragen
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Type I
    8.8.2.2 Type II
    8.8.2.3 Type III
  8.8.3 Asuragen 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Asuragen 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.9 BG Medicine
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Type I
    8.9.2.2 Type II
    8.9.2.3 Type III
  8.9.3 BG Medicine 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 BG Medicine 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis
8.10 Biocartis
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Type I
    8.10.2.2 Type II
    8.10.2.3 Type III
  8.10.3 Biocartis 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Biocartis 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET

9.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Trend Analysis
  9.1.1 Global 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Forecast
9.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Regional Market Trend
  9.2.1 North America 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Forecast
  9.2.2 China 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Forecast
  9.2.3 Europe 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Forecast
  9.2.4 Southeast Asia 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Forecast
  9.2.5 Japan 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Forecast
  9.2.6 India 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Forecast
9.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Trend (Product Type)
9.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Trend (Application)

10 COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKETING TYPE ANALYSIS

10.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Regional Marketing Type Analysis
10.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions
10.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Supply Chain Analysis

11 CONSUMERS ANALYSIS OF COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET PROFESSIONAL SURVEY REPORT 2016

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Product Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Classification of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Production Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Type in 2015
Figure Consumables Picture
Table Major Manufacturers of Consumables
Figure Services Picture
Table Major Manufacturers of Services
Figure Software Picture
Table Major Manufacturers of Software
Table Applications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Consumption Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Application in 2015
Figure Oncology Examples
Table Major Consumers of Oncology
Figure Cardiology Examples
Table Major Consumers of Cardiology
Figure Neurology Examples
Table Major Consumers of Neurology
Figure Others Examples
Table Major Consumers of Others
Figure Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2011-2021)
Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2011-2021)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2011-2021)
Figure Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2011-2021)
Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2011-2021)
Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2011-2021)
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in 2015
Figure Manufacturing Process Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Industry Chain Structure of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Capacity (Unit) and Commercial Production Date of Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Manufacturers in 2015
Table Global Capacity (Unit), Sales (Unit), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Figure Global 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Value) and Growth Rate
Table 2011-2016E Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Capacity and Growth Rate
Table 2015 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Capacity List (Company Segment)
Table 2011-2016E Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate
Table 2015 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales List (Company Segment)
Table 2011-2016E Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price
Table 2015 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (Unit)
Figure North America 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price (USD/Unit)
Figure North America 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (Unit)
Figure China 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price (USD/Unit)
Figure China 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (Unit)
Figure Europe 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price (USD/Unit)
Figure Europe 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (Unit)
Figure Southeast Asia 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price (USD/Unit)
Figure Southeast Asia 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (Unit)
Figure Japan 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price (USD/Unit)
Figure Japan 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (Unit)
Figure India 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price (USD/Unit)
Figure India 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share
Table Global 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type
Table Different Types Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Interview Price
Table Global 2011-2016E Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application
Table Different Application Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Interview Price
Table 20/20 GeneSystems Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 20/20 GeneSystems Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 20/20 GeneSystems 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table Activiomic Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 Activiomic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 Activiomic 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table Advanced Cell Diagnostics Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 Advanced Cell Diagnostics Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 Advanced Cell Diagnostics 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table Agendia Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 Agendia 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table Almac Diagnostics Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 Almac Diagnostics Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 Almac Diagnostics 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table Arrayit Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 Arrayit 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table Astute Medical Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 Astute Medical Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 Astute Medical 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table Asuragen Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 Asuragen Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 Asuragen 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table BG Medicine Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 BG Medicine 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Table Biocartis Information List
Table Type I Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type II Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table Type III Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview
Table 2015 Biocartis Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Sales, Ex-factory Price
Figure 2015 Biocartis 2015 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business Region Distribution
Figure Global 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price (USD/Unit) Forecast
Figure North America 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2016-2021
Table Global Consumption Volume (Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2016-2021
Table Traders or Distributors with Contact Information of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions
Table Part of Interviewees Record List